Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...
A groundbreaking gene therapy has successfully restored immune function in children with ADA-SCID, a severe genetic disorder.
The study, published in the New England Journal of Medicine, marks the largest and longest follow-up of this gene therapy to ...
Everybody's a sucker for a comeback story, including staff at Roper St. Francis Mount Pleasant Hospital that witnessed the recent renaissance of their beloved 7-year-old Labrador/Boxer, Riggs. Named ...